Veterans Affairs Pharmacist Heart Failure Medication Titration Project 1
- Conditions
- Heart Failure
- Registration Number
- NCT06099808
- Lead Sponsor
- Stanford University
- Brief Summary
This is a randomized quality improvement project to evaluate the impact of an audit and feedback intervention to motivate pharmacists to provide heart failure (HF) medication management to patients in the Veterans Health Administration (VHA) Sierra Pacific region (VISN 21). The results of this project could provide guidance for how to successfully scale a pharmacist-based HF remote management program in the VHA more broadly.
Pharmacists providing clinical care as part of Patient Aligned Care Team (PACT) within VHA VISN 21 will be included. Pharmacists will be randomized to one of 3 arms in a 1:1:2 ratio: (1) monthly audit and feedback of HF medication titration activities (AF) vs. (2) educational resources and monthly notification of HF medication titration actions in addition to a list of potential patients for HF optimization (AF+) vs. (3) usual care without audit and feedback (UC). Pharmacists across all three arms will be given access to shared educational resources on HF pharmacist care and educational webinars. Six months after the intervention, rates of pharmacist HF medication titration encounters will be compared among the 3 groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 110
- Clinical pharmacists in the Veterans Health Administration that provide Patient Aligned Care Team (PACT) care in VA Sierra Pacific Network (VISN 21)
- Excluded per pharmacist supervisor decision
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of monthly heart failure medication adjustment encounters 2 months post-randomization to 6 months post-randomization Encounters in which pharmacist adjusted heart failure medications
- Secondary Outcome Measures
Name Time Method Beta-blocker therapy At 6 months post randomization Percentage of patients with heart failure with reduced ejection fraction in each pharmacist panel that are treated with beta-blocker therapy
Number of new patients with pharmacist HF management Within 6 months post-randomization For each pharmacist, will calculate the number of patients with heart failure in their panel that receive care from pharmacist that were not receiving care prior to randomization
Guideline medical therapy score At 6 months post randomization Composite score of heart failure medical therapy among patients with heart failure for patients within each pharmacists panel
Renin-angiotensin system inhibitor (RASI) therapy At 6 months post randomization Percentage of patients with heart failure with reduced ejection fraction in each pharmacist panel that are treated with RASI therapy
Percentage of heart failure patients with medication management by pharmacist Within 6 months post-randomization For each pharmacist, will calculate the percentage of patients with heart failure in their panel that receive medication adjustments from pharmacist
Angiotensin receptor neprilysin inhibitor (ARNI) therapy At 6 months post randomization Percentage of patients with heart failure with reduced ejection fraction in each pharmacist panel that are treated with ARNI therapy
Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) therapy At 6 months post randomization Percentage of patients with heart failure in each pharmacist panel that are treated with SGLT2i therapy
Mineralocorticoid receptor antagonist (MRA) therapy At 6 months post randomization Percentage of patients with heart failure in each pharmacist panel that are treated with MRA therapy
Trial Locations
- Locations (1)
Palo Alto Veteran's Affairs Hospital
🇺🇸Palo Alto, California, United States
Palo Alto Veteran's Affairs Hospital🇺🇸Palo Alto, California, United States